The Diabetic Technology Press by Alertgy

Alertgy Takes Top Prize International DxPx Conference Competition

Alertgy, a pioneer in 100% non-invasive continuous blood glucose monitoring won first place for the most disruptive medical technology in 2021 at a recently held DxPx Conference in Dusseldorf, Germany.  Prior to this award, Alertgy secured top spot in DxPx’ North American competition. The prize, valued between $500,000 and $1,000,000 was sought by 237 applicants and 8 finalists globally.

Alertgy Welcomes Executive-Level Director of Engineering

Alertgy brings on two new acclaimed engineers to the team. We are happy to welcome Ben and Will to the team, and we are excited to see what the future holds.

Showcasing a Groundbreaking Possibility for Alertgy's Non-Invasive Propriety Sensor Technology for Detecting Covid-19

Alertgy is in the process of developing two key components to execute this research study- (1) an electret mask with a microfiber matrix to trap viral particles and (2) an in vitro dielectric analyzer unit, which includes Alertgy’s dielectric sensor and a custom-engineered reservoir for the real-time analysis of the microfiber matrix from the mask.

Alertgy Expands Into New Facility After Successful FlexTech Developer Partnership

Alertgy has expanded its capabilities with our new location expansion in Melbourne, Florida along with being awarded a Developers Agreement between Alertgy Inc. and SEMI Flex Tech.

The New Med Tech Company That's Changing Glucose Sensor Technology

Alertgy is a cutting-edge biotech company working to revolutionize the way diabetics and pre-diabetics manage their diabetes. Alertgy has developed a technology that is unlike any other currently on the market.

What You Should Know About Alertgy's Deep-Gluco® AI driven Glucose Sensor

The Alertgy NICGM (Non-Invasive Continuous Glucose Monitor) is a one of a kind AI technology that gives diabetics and pre diabetics an easier, more cost efficient, and less painful way to monitor and manage their diabetes.